Bimaneshwar Biswas
Research Subjects
Bimaneshwar Biswas has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Deepannita Roy Mukherjee
Department of Pharmacology, JRSET College of Pharmacy, Panchpota, Chakdah, Nadia–741222, West Bengal, India
1 shared publication - Mostafijur Rahaman
Department of Pharmacology, Maulana Abul Kalam Azad University of Technology (WB) Haringhata Farm, West Bengal
1 shared publication - Pinki Biswas
Department of Pharmaceutics, JRSET College of Pharmacy, Panchpota, Chakdah, Nadia–741222, West Bengal, India
1 shared publication - Raktim Sarkar
Bengal School of Technology
1 shared publication - Saikat Santra
Department of Pharmaceutics, JRSET College of Pharmacy, Panchpota, Chakdah, Nadia–741222, West Bengal, India
1 shared publication - Sayak Tanbir
Department of Pharmacology, Maulana Abul Kalam Azad University of technology (WB) Haringhata Farm, West Bengal 741249
1 shared publication
Latest Publications
- Open Access
- 15 October 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (10) , 148-171
Chrono-Colonic Delivery in Engineering Time-Responsive Systems for Site-Specific Therapy
Background: Chrono-colonic drug delivery represents a novel pharmaceutical engineering strategy that combines the principles of circadian rhythm-based chronotherapy with colon-targeted the drug delivery. This approach seeks to optimize therapeutic efficacy by synchronizing drug release with the body’s biological clock while ensuring precise site-specific delivery. Objective: The primary aim of chrono-colonic delivery is to achieve controlled drug release after a predetermined lag time, ensuring that the therapeutic effect coincides with peak disease activity and that the drug reaches the colon for localized or systemic action. Methods: This strategy integrates time-dependent and site-specific technologies, employing pH-sensitive polymers, biodegradable coatings, osmotic systems, and microbially triggered release platforms. These delivery systems are designed to withstand the upper gastrointestinal tract environment and to release the active agent in the colon, where favorable physiological conditions such as near-neutral pH, slower motility, and microbial activity can be exploited. Results: Chrono-colonic delivery systems offer significant therapeutic benefits, including improved precision of drug action, reduced systemic side effects, and enhanced patient compliance. They are particularly beneficial in managing diseases with circadian variability, such as asthma, hypertension, arthritis, ulcerative colitis, and inflammatory bowel disease. Conclusion: By integrating chrono-therapeutic principles with colon-targeted technologies, chrono-colonic drug delivery holds promise as a next-generation approach for achieving site- and time-specific therapy. It represents a forward-looking strategy for addressing both local and systemic diseases with enhanced safety and efficacy. Keywords: Chrono-Colonic Delivery, Circadian Rhythm, Colon-Targeted Drug Delivery, Time-Responsive Systems, Site-Specific Therapy, Chronotherapy
- 15 October 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (10) , 148-171
Open AccessChrono-Colonic Delivery in Engineering Time-Responsive Systems for Site-Specific Therapy
Background: Chrono-colonic drug delivery represents a novel pharmaceutical engineering strategy that combines the principles of circadian rhythm-based chronotherapy with colon-targeted the drug delivery. This approach seeks to optimize therapeutic efficacy by synchronizing drug release with the body’s biological clock while ensuring precise site-specific delivery. Objective: The primary aim of chrono-colonic delivery is to achieve controlled drug release after a predetermined lag time, ensuring that the therapeutic effect coincides with peak disease activity and that the drug reaches the colon for localized or systemic action. Methods: This strategy integrates time-dependent and site-specific technologies, employing pH-sensitive polymers, biodegradable coatings, osmotic systems, and microbially triggered release platforms. These delivery systems are designed to withstand the upper gastrointestinal tract environment and to release the active agent in the colon, where favorable physiological conditions such as near-neutral pH, slower motility, and microbial activity can be exploited. Results: Chrono-colonic delivery systems offer significant therapeutic benefits, including improved precision of drug action, reduced systemic side effects, and enhanced patient compliance. They are particularly beneficial in managing diseases with circadian variability, such as asthma, hypertension, arthritis, ulcerative colitis, and inflammatory bowel disease. Conclusion: By integrating chrono-therapeutic principles with colon-targeted technologies, chrono-colonic drug delivery holds promise as a next-generation approach for achieving site- and time-specific therapy. It represents a forward-looking strategy for addressing both local and systemic diseases with enhanced safety and efficacy. Keywords: Chrono-Colonic Delivery, Circadian Rhythm, Colon-Targeted Drug Delivery, Time-Responsive Systems, Site-Specific Therapy, Chronotherapy